Erik Stoops

4.8k total citations · 2 hit papers
72 papers, 2.5k citations indexed

About

Erik Stoops is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Erik Stoops has authored 72 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 29 papers in Psychiatry and Mental health and 23 papers in Molecular Biology. Recurrent topics in Erik Stoops's work include Alzheimer's disease research and treatments (55 papers), Dementia and Cognitive Impairment Research (28 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Erik Stoops is often cited by papers focused on Alzheimer's disease research and treatments (55 papers), Dementia and Cognitive Impairment Research (28 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Erik Stoops collaborates with scholars based in Belgium, Netherlands and United States. Erik Stoops's co-authors include Hugo Vanderstichele, Charlotte E. Teunissen, Inge M.W. Verberk, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Eugeen Vanmechelen, Wiesje M. van der Flier, Manu Vandijck and Nicholas J. Ashton and has published in prestigious journals such as Brain, Stroke and Scientific Reports.

In The Last Decade

Erik Stoops

70 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

2021 276 citations Pratishtha Chatterjee, Steve Pedrini et al. Translational Psychiatry profile →
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

2022 242 citations Jeroen Vanbrabant, Erik Stoops et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Stoops Belgium	24	1.5k	1.1k	625	564	518	72	2.5k
Christoffer Rosén Sweden	13	1.4k 0.9×	975 0.9×	433 0.7×	741 1.3×	485 0.9×	14	2.4k
Daniel Alcolea Spain	35	1.5k 1.0×	906 0.8×	845 1.4×	889 1.6×	594 1.1×	112	3.1k
Henrik Zetterberg Sweden	28	1.1k 0.7×	753 0.7×	602 1.0×	640 1.1×	418 0.8×	172	2.5k
Juan Lantero‐Rodriguez Sweden	26	1.8k 1.1×	1.4k 1.3×	350 0.6×	733 1.3×	424 0.8×	54	2.8k
Inge M.W. Verberk Netherlands	22	1.4k 0.9×	1.2k 1.1×	382 0.6×	473 0.8×	486 0.9×	74	2.2k
Nicolas R. Barthélemy United States	23	1.5k 1.0×	837 0.8×	351 0.6×	688 1.2×	372 0.7×	43	2.4k
Kina Höglund Sweden	29	1.4k 0.9×	686 0.6×	606 1.0×	743 1.3×	456 0.9×	68	2.5k
Maartje I. Kester Netherlands	22	1.1k 0.7×	898 0.8×	391 0.6×	356 0.6×	445 0.9×	35	1.7k
Armand Perret‐Liaudet France	28	1.1k 0.7×	771 0.7×	735 1.2×	1.2k 2.1×	639 1.2×	89	2.7k
Sanna‐Kaisa Herukka Finland	34	1.9k 1.3×	1.3k 1.2×	891 1.4×	889 1.6×	636 1.2×	106	3.5k

Countries citing papers authored by Erik Stoops

Since Specialization

Citations

This map shows the geographic impact of Erik Stoops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Stoops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Stoops more than expected).

Fields of papers citing papers by Erik Stoops

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Stoops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Stoops. The network helps show where Erik Stoops may publish in the future.

Co-authorship network of co-authors of Erik Stoops

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Stoops. A scholar is included among the top collaborators of Erik Stoops based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Stoops. Erik Stoops is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cline, Erika N., Karen Sundell, Elizabeth A. Johnson, et al.. (2025). Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease. The Journal of Prevention of Alzheimer s Disease. 12(4). 100082–100082. 2 indexed citations

Berg, E. van den, Iris Kersten, Gunnar Brinkmalm, et al.. (2024). Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy. Journal of Neurochemistry. 168(7). 1254–1264. 3 indexed citations

Vanbrabant, Jeroen, Sjors G. J. G. In ‘t Veld, Rebecca M. Edelmayer, et al.. (2023). Plasma phosphorylated tau 217 levels are highly stable under common pre‐analytical sample handling procedures. Alzheimer s & Dementia. 19(S14). 1 indexed citations

Mancini, Andrea, Erik Stoops, Giovanni Bellomo, et al.. (2023). LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes. Movement Disorders. 38(4). 682–688. 3 indexed citations

Vanbrabant, Jeroen, Steffi De Meyer, Carrie E. Rubel, et al.. (2023). Performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays. Alzheimer s & Dementia. 19(S15). 1 indexed citations

Vanbrabant, Jeroen, Sherif Bayoumy, Inge M.W. Verberk, et al.. (2023). Performance of optimized prototype LUMIPULSE G immunoassays for plasma pTau181 and pTau217. Alzheimer s & Dementia. 19(S24). 2 indexed citations

Lashuel, Hilal A., Anne‐Laure Mahul‐Mellier, Salvatore Novello, et al.. (2022). Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity. npj Parkinson s Disease. 8(1). 136–136. 33 indexed citations

Kumar, Pankaj, Jeroen Vanbrabant, Mary Joy Encarnacion, et al.. (2022). The effects of age and sex on plasma p‐tau181 concentrations in Alzheimer’s Disease. Alzheimer s & Dementia. 18(S5). 1 indexed citations

Kort, Anna M. de, H. Bea Kuiperij, Daniel Alcolea, et al.. (2021). Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 13(1). 160–160. 6 indexed citations

10.

Schmitz, Matthias, Angela da Silva Correia, Susana Correia, et al.. (2021). Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders. 37(1). 39–51. 17 indexed citations

11.

Chatterjee, Pratishtha, Steve Pedrini, Erik Stoops, et al.. (2021). Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Translational Psychiatry. 11(1). 27–27. 276 indexed citations breakdown →

12.

Doecke, James D., Cindy François, Christopher Fowler, et al.. (2021). Core Alzheimer’s disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. Alzheimer s Research & Therapy. 13(1). 79–79.

13.

Thijssen, Elisabeth H., Inge M.W. Verberk, Jeroen Vanbrabant, et al.. (2021). Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease. Scientific Reports. 11(1). 9736–9736. 52 indexed citations

14.

Candelise, Niccolò, Matthias Schmitz, Katrin Thüne, et al.. (2020). Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays. Translational Neurodegeneration. 9(1). 5–5. 57 indexed citations

15.

Geukens, Nick, Sabiha Eddarkaoui, Vanessa Franssens, et al.. (2020). A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms. Frontiers in Molecular Biosciences. 7. 48–48. 6 indexed citations

16.

Hilal, Saima, M. Arfan Ikram, Marcel M. Verbeek, et al.. (2018). C-Reactive Protein, Plasma Amyloid-β Levels, and Their Interaction With Magnetic Resonance Imaging Markers. Stroke. 49(11). 2692–2698. 48 indexed citations

17.

Schmitz, Matthias, Anna Villar‐Piqué, Franc Llorens, et al.. (2018). Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy. Molecular Neurobiology. 56(5). 3476–3483. 23 indexed citations

18.

Hilal, Saima, Frank J. Wolters, Marcel M. Verbeek, et al.. (2018). Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study. Alzheimer s Research & Therapy. 10(1). 63–63. 42 indexed citations

19.

Lerche, Stefanie, Kathrin Brockmann, Andrea Pilotto, et al.. (2016). Prospective longitudinal course of cognition in older subjects with mild parkinsonian signs. Alzheimer s Research & Therapy. 8(1). 42–42. 18 indexed citations

20.

Oelemann, Walter, Bram Vanderborght, G Costa, et al.. (1999). A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas' disease. Transfusion. 39(7). 711–717. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact